As discussed in gut health research more broadly, microbiome disruption drives: Intestinal permeability Systemic inflammation Impaired neurotransmitter production Immune dysregulation In the context of long COVID, gut dysfunction may represent both a consequence of the initial infection and an ongoing driver of systemic inflammatory and neurological symptoms
Rather than waiting until all the weight is lost and then starting to address skin laxity, early intervention gives the skin a head start on remodeling
BodySculp: BodySculp utilizes advanced diode-laser energy to target adipose tissue, permanently destroying stubborn fat cells and reducing cellulite
Here are the directions generating the most clinical interest as we move through 2026: Gut-Brain Axis Applications Emerging research is exploring BPC-157s role in modulating the gut-brain axis the bidirectional communication network between the gastrointestinal system and the central nervous system
A., Hellman, U., Tornqvist, H
BPC-157 is also notable for an unusual proteolytic stability profile in gastric juice, which forms part of the rationale for oral research applications, although no human pharmacokinetic data have been published
